Cargando…
SGLT2 inhibitors: An answer to diabetes or a question to its complications?
Autores principales: | Priya, Kumar, Ayush, Khatri, Govinda, Hasan, Mohammad Mehedi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213700/ https://www.ncbi.nlm.nih.gov/pubmed/35757315 http://dx.doi.org/10.1016/j.amsu.2022.103992 |
Ejemplares similares
-
Mediastinal lymphadenopathy: A serious complication in COVID-19 patients
por: Khatri, Govinda, et al.
Publicado: (2022) -
Statins: Masked anti-epileptic warriors
por: Khatri, Govinda, et al.
Publicado: (2022) -
CABG versus PCI: What is the optimal strategy for multi-vessel disease?
por: Kumar, Ayush, et al.
Publicado: (2022) -
Hydrochlorothiazide: A savior to the heart or a foe to the skin?
por: Kumar, Ayush, et al.
Publicado: (2022) -
A Question of Ethics: Answer Wanted
Publicado: (1889)